tirzepatide

weight loss scale weigh measure tape obesity overweight
Biotech

Pfizer’s new prize Metsera touts 14% weight loss for GLP-1

The drug at the center of Pfizer’s buyout has been tied to 14.1% weight loss at 28 weeks as well as “potentially class-leading tolerability.”
James Waldron Sep 30, 2025 6:40am
cancel

Lilly withdraws phase 2 obesity trial before starting enrollment

Sep 25, 2025 8:07am
head to head against clash football helmets fight combat

BrightGene tops Novo drug in diabetes ahead of Zepbound showdown

Jun 23, 2025 2:30pm
pipelines in the sun

Lilly's next focus: Testing incretins in neuro, immunology fields

Feb 6, 2025 2:35pm
Close up of horse legs and hooves running on sand track

Biolexis enters small molecule into oral GLP-1 horse race

Sep 13, 2024 12:24pm
pond lilly pads

Arrowhead dips toes into obesity pond with 2 preclinical assets

Aug 14, 2024 3:50pm